Michael Wayne Kalb
CIK 1678248 · Executive Vice President & CFO · last filed 2026-01-06
Michael Wayne Kalb is an Executive Vice President & CFO who has filed 48 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for CPRX, was dated Jan 6, 2026. Across all open-market trades the lifetime net is −$10.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.77M
4
48
-$10.41M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CPRX | Executive Vice President & CFO | 13,665 | $31.36 | $428.5K | $0 | 4 | 2026-01-06 |
| IPI Legacy Liquidation Co (IMPL) Delisted | CFO | — | $0.24 | — | $0 | 1 | 2023-05-12 |
| CinCor Pharma, Inc. (CINC) Delisted | EVP & Chief Financial Officer | 0 | $29.06 | $0 | $0 | 3 | 2023-02-24 |
| AMRN | SVP and CFO | 284,662 | $15.24 | $4.34M | -$10.41M | 40 | 2022-08-02 |
Recent Filings
48 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-06 | CPRX | Mixed | +5,059 | $0 | EDGAR |
| 2025-11-24 | CPRX | Mixed | +4,409 | $0 | EDGAR |
| 2025-01-03 | CPRX | Mixed | +4,197 | $0 | EDGAR |
| 2024-11-25 | CPRX | Grant (A) | — | $0 | EDGAR |
| 2023-05-12 | IPI Legacy Liquidation Co (IMPL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-24 | CinCor Pharma, Inc. (CINC) Delisted | Disp (D) | −202,437 | $0 | EDGAR |
| 2023-01-30 | CinCor Pharma, Inc. (CINC) Delisted | Grant (A) | +177,000 | $0 | EDGAR |
| 2022-11-08 | CinCor Pharma, Inc. (CINC) Delisted | Grant (A) | +25,437 | $0 | EDGAR |
| 2022-08-02 | AMRN | Mixed | +865 | -$62.4K | EDGAR |
| 2022-03-02 | AMRN | Mixed | +10,120 | -$20.3K | EDGAR |